These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 16496364)

  • 21. Impact of tumor length on long-term survival of pT1 esophageal adenocarcinoma.
    Bolton WD; Hofstetter WL; Francis AM; Correa AM; Ajani JA; Bhutani MS; Erasmus J; Komaki R; Maru DM; Mehran RJ; Rice DC; Roth JA; Vaporciyan AA; Walsh GL; Swisher SG
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):831-6. PubMed ID: 19660349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival effect of neoadjuvant radiotherapy before esophagectomy for patients with esophageal cancer: a surveillance, epidemiology, and end-results study.
    Schwer AL; Ballonoff A; McCammon R; Rusthoven K; D'Agostino RB; Schefter TE
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):449-55. PubMed ID: 18538500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How does the number of resected lymph nodes influence TNM staging and prognosis for esophageal carcinoma?
    Hu Y; Hu C; Zhang H; Ping Y; Chen LQ
    Ann Surg Oncol; 2010 Mar; 17(3):784-90. PubMed ID: 19953333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of CyclinD1 and E-Cadherin in patients with esophageal squamous cell carcinoma: multiinstitutional retrospective analysis. Research Committee on Malignancy of Esophageal Cancer, Japanese Society for Esophageal Diseases.
    J Am Coll Surg; 2001 Jun; 192(6):708-18. PubMed ID: 11400964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathologic prognostic factors in Barrett's associated adenocarcinoma: a follow-up study of 96 patients.
    Torres C; Turner JR; Wang HH; Richards W; Sugarbaker D; Shahsafaei A; Odze RD
    Cancer; 1999 Feb; 85(3):520-8. PubMed ID: 10091725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma.
    Shimada H; Nabeya Y; Okazumi S; Matsubara H; Shiratori T; Gunji Y; Kobayashi S; Hayashi H; Ochiai T
    Surgery; 2003 May; 133(5):486-94. PubMed ID: 12773976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic value of circumferential resection margin involvement in oesophageal malignancy.
    Griffiths EA; Brummell Z; Gorthi G; Pritchard SA; Welch IM
    Eur J Surg Oncol; 2006 May; 32(4):413-9. PubMed ID: 16504455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas.
    Miyata H; Yamasaki M; Kurokawa Y; Takiguchi S; Nakajima K; Fujiwara Y; Konishi K; Mori M; Doki Y
    Ann Surg Oncol; 2011 Nov; 18(12):3353-61. PubMed ID: 21537861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multivariate analysis of clinicopathological factors influencing survival following esophagectomy for cancer.
    Mirnezami R; Rohatgi A; Sutcliffe RP; Hamouda A; Chandrakumaran K; Botha A; Mason RC
    Int J Surg; 2010; 8(1):58-63. PubMed ID: 19897061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
    Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
    J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histological regression of squamous esophageal carcinoma assessed by percentage of residual viable cells after neoadjuvant chemoradiation is an important prognostic factor.
    Tong DK; Law S; Kwong DL; Chan KW; Lam AK; Wong KH
    Ann Surg Oncol; 2010 Aug; 17(8):2184-92. PubMed ID: 20217248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of factors influencing long-term survival after surgical resection for oesophageal squamous cell carcinoma.
    Kolh P; Honore P; Gielen JL; Degauque C; Azzam C; Legrand M; Jacquet N
    Acta Chir Belg; 1999; 99(3):113-8. PubMed ID: 10427345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Esophagectomy with extended lymphadenectomy for submucosal esophageal cancer: long-term outcomes and prognostic factors.
    Tanaka T; Matono S; Nagano T; Shirouzu K; Fujita H; Yamana H
    Ann Surg Oncol; 2012 Mar; 19(3):750-6. PubMed ID: 21861216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Result of surgical treatment and prognostic factors in giant mass lung cancer].
    Xu BB; Gao W; Chen C; Wei N; Zheng H; Zhou Y; Zhang RX
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):632-5. PubMed ID: 18210889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Importance of fluorodeoxyglucose-positron emission tomography (FDG-PET) and endoscopic ultrasonography parameters in predicting survival following surgery for esophageal cancer.
    Omloo JM; Sloof GW; Boellaard R; Hoekstra OS; Jager PL; van Dullemen HM; Fockens P; Plukker JT; van Lanschot JJ
    Endoscopy; 2008 Jun; 40(6):464-71. PubMed ID: 18543134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Surgical treatment of gasto-esophageal junction adenocarcinoma: long-term results of a single Italian centre].
    Pedrazzani C; Pasini F; Giacopuzzi S; Bernini M; Ruzzenente A; Festini M; Tomasi I; Cristadoro L; de Manzoni G
    G Chir; 2004 Oct; 25(10):325-33. PubMed ID: 15756954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patients with locally advanced esophageal carcinoma nonresponder to radiochemotherapy: who will benefit from surgery?
    Piessen G; Briez N; Triboulet JP; Mariette C
    Ann Surg Oncol; 2007 Jul; 14(7):2036-44. PubMed ID: 17453293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. All pathological T4 esophageal carcinomas should be categorized as stage IV.
    Tabira Y; Yasunaga M; Nakano KY; Sakaguchi T; Nagamoto N; Matsushita H; Fukunaga Y
    Hepatogastroenterology; 2002; 49(45):694-8. PubMed ID: 12063972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic relevance of histomorphological parameters and DNA content and their therapeutic consequences in esophageal carcinoma: a multivariate approach.
    Boettger T; Dutkowski P; Kirkpatrick CJ; Seifert JK; Junginger T
    Hepatogastroenterology; 1998; 45(22):994-1004. PubMed ID: 9755996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.